Medenas, Athanasia – Trademark Portfolio

Entity Type: 01

Medenas, Athanasia holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SHAMANIC YOGA. The owner is based in La Jolla, CA.

C/O Buche & Associates PC

875 Prospect St, Suite 305

La Jolla, CA 92037

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Medenas, Athanasia's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Medenas, Athanasia have?

Medenas, Athanasia has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Medenas, Athanasia file in?

Medenas, Athanasia files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Medenas, Athanasia's most well-known trademarks?

Medenas, Athanasia's registered trademark portfolio includes well-known marks such as SHAMANIC YOGA. These are among 1 currently registered trademark in the portfolio.

What is Medenas, Athanasia's trademark registration success rate?

Medenas, Athanasia has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.